Merck, the Dow's hottest stock, gets set to report Q4 financials Shareholders of Organon & Co. (NYSE:OGN) approved the ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a ...

Sun Pharmaceutical Industries on Friday announced that the stockholders of Organon & Co. have approved the proposals in ...

Among the notable losers were Sun Pharmaceutical Industries Ltd, Biocon Ltd, Torrent Pharmaceuticals Ltd, Dr Reddy's ...

Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma and Zydus Lifesciences were among the top losers on the Nifty Pharma ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Sun Pharma receives SAHPRA approval to market a generic semaglutide injection for type 2 diabetes in South Africa.

Sun Pharma drew more unwanted attention this week when India’s stock regulators confirmed they are examining whistleblower allegations against the company. “We have received the complaint against Sun ...

India Healthcare at Bernstein believes higher drug prices, supply shortages and a gradual shift in manufacturing to the US ...

After navigating a series of manufacturing problems in recent months, Sun Pharma has now been forced to respond to an entirely different type of issue. Last week, Mumbai, India-based Sun Pharma ...

Sun Pharmaceutical Industries said on Friday that it has crossed a key milestone in its proposed acquisition of US-based Organon & Co after the latter's shareholders approved the merger.